Litcius/Paper detail

Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy

Sarah K. Jacques, Janet McKeown, Piyush Grover, Douglas B. Johnson, Anne Zaremba, Florentia Dimitriou, Roi Weiser, Mohamad Farid, Kenjiro Namikawa, Ryan J. Sullivan, Piotr Rutkowski, Célèste Lebbé, Omid Hamid, Jonathan S. Zager, Olivier Michielin, Bart Neyns, Yasuhiro Nakamura, Caroline Robert, Janice M. Mehnert, Paolo A. Ascierto, Prachi Bhave, Benjamin Park, Lisa Zimmer, Joanna Mangana, Megan Mooradian, Joanna Placzke, Clare Allayous, Isabella C. Glitza Oliva, Inderjit Mehmi, Danielle K. DePalo, Alexandre Wicky, Julia Katharina Schwarze, Séverine Le Roy, Christina Boatwright, Vito Vanella, Georgina V. Long, Alexander M. Menzies, Serigne Lo, Matteo S. Carlino

2024European Journal of Cancer20 citationsDOI

Topics & Concepts

MedicineAdjuvantMelanomaAdjuvant therapyStage (stratigraphy)Internal medicineGastroenterologyMucosal melanomaOncologySurgeryChemotherapyCancer researchBiologyPaleontologyCutaneous Melanoma Detection and ManagementNonmelanoma Skin Cancer StudiesCancer Immunotherapy and Biomarkers